J9029
HCPCSInstill adstiladrin, tx dose
Official HCPCS Level II long descriptor
Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose
HCPCS Level II code J9029 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Instill adstiladrin, tx dose
Added to HCPCS: 2023-07-01
Nearby codes in J9
- J9021Inj, aspara, rylaze, 0.1 mg
- J9022Inj, atezolizumab,10 mg
- J9023Injection, avelumab, 10 mg
- J9024Inj atezolizumb 5mg hya-tqjs
- J9025Azacitidine injection
- J9026Inj, tarlatamab-dlle, 1 mg
- J9027Clofarabine injection
- J9028Inj, nogapendekin pmln, 1mcg
- J9030Bcg live intravesical 1mg
- J9032Injection, belinostat, 10mg
- J9033Inj, bendamustine hcl, 1mg
- J9034Inj., bendeka 1 mg
- J9035Bevacizumab injection
- J9036Inj. belrapzo/bendamustine
- J9038Inj axatilimab-csfr 0.1 mg
- J9039Injection, blinatumomab
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.